Esperion Therapeutics (ESPR) Intangibles (2012 - 2022)
Esperion Therapeutics (ESPR) posted Intangibles of $56000.0 for Q4 2022, little changed on a QoQ basis from $56000.0 in Q4 2021, and little changed year-over-year from $56000.0 in Q4 2021.
Esperion Therapeutics (ESPR) Intangibles (2012 - 2022) Analysis & Trends
Esperion Therapeutics' Intangibles history runs 11 years deep, the most recent figure standing at $56000.0 for Q4 2022.
- Quarterly Intangibles changed 0.0% year-over-year to $56000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $56000.0 (changed 0.0% YoY) and the FY2022 annual result came in at $56000.0, changed 0.0% from the prior year.
- Intangibles was $56000.0 for Q4 2022 at Esperion Therapeutics, roughly flat from $56000.0 in the prior quarter.
- Across five years, Intangibles topped out at $56000.0 in Q1 2018 and bottomed at $56000.0 in Q1 2018.
- A 5-year average of $56000.0 and a median of $56000.0 in 2018 frame the typical range for Intangibles.
- Peak annual rise in Intangibles reached 0.0% in 2018, while the deepest fall reached 0.0% in 2018.
- Esperion Therapeutics' Intangibles stood at $56000.0 in 2018, then changed by 0.0% to $56000.0 in 2019, then changed by 0.0% to $56000.0 in 2020, then changed by 0.0% to $56000.0 in 2021, then changed by 0.0% to $56000.0 in 2022.
- Business Quant data shows ESPR's Intangibles at $56000.0 in Q4 2022, $56000.0 in Q4 2021, and $56000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Esperion Therapeutics | 799.30 Mn | 643.14 Mn | 45.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 56,000.00 |
| Dec 31, 2020 | 56,000.00 |
| Mar 31, 2020 | 56,000.00 |
| Dec 31, 2019 | 56,000.00 |
| Sep 30, 2019 | 56,000.00 |
| Jun 30, 2019 | 56,000.00 |
| Mar 31, 2019 | 56,000.00 |
| Dec 31, 2018 | 56,000.00 |
| Sep 30, 2018 | 56,000.00 |
| Jun 30, 2018 | 56,000.00 |
| Mar 31, 2018 | 56,000.00 |
| Dec 31, 2017 | 56,000.00 |
| Sep 30, 2017 | 56,000.00 |
| Jun 30, 2017 | 56,000.00 |
| Mar 31, 2017 | 56,000.00 |
| Dec 31, 2016 | 56,000.00 |
| Sep 30, 2016 | 56,000.00 |
| Jun 30, 2016 | 56,000.00 |
| Mar 31, 2016 | 56,000.00 |